Receive a free case review.
Raptiva Deaths
According to an FDA health advisory issued February 19, 2009, the psoriasis drug Raptiva has been linked to at least 3 deaths. The FDA has confirmed that two of the Raptiva patients’ deaths were caused by a severe brain infection called progressive multifocal leukoencephalopathy, or PML. The other death is suspected to have been caused by PML as well.
In October 2008, Genentech, the company that markets Raptiva in the United States, added a "black box" warning to Raptiva after the first PML death was reported in a Raptiva patient. PML is caused by a polyomavirus, called the JC virus. It leads to an irreversible decline in neurologic function and often causes severe disability or death. There is no known treatment for PML.
The FDA is currently reviewing the three Raptiva-related deaths. All three patients were treated with Raptiva continuously for more than three years and ranged in age from 47 to 73 years old. None were receiving other treatments that suppress the immune system, the FDA said.
The European Medicines Agency (EMEA) has already recommended that sales of Raptiva be suspended in Europe in light of the serious brain
|
Related Topics: Dangerous Product Alert: Legal News: |
Raptiva Wrongful Death Attorney
If you or a loved one took Raptiva and experienced serious side effects, or you suspect your loved one’s death was caused by Raptiva, you should contact one of our Raptiva wrongful death lawyers immediately to discuss your legal rights and options.
Depending on your particular circumstances, our Raptiva wrongful death attorneys may be able to help you collect monetary compensation for your injuries, including compensation for:
- medical bills
- lost income
- pain and suffering
- burial costs
- more
Contact our experienced Raptiva wrongful death attorneys today for a free and confidential case evaluation.
BOOKMARK SITE
ADD TO DEL.ICIO.US
EMAIL THIS PAGE
Legal News RSS
